Lack of Access, Not Lack of Interest, Prevents Black Patients From Enrolling in Clinical Trials
More than 80% of Black survey respondents said they were somewhat or very likely to consider enrolling in a clinical trial.
All articles by John Schieszer, MA
FDA Aims To Improve Medical Device Security
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.
Increasing Public Welfare Spending Can Improve Survival for Black Cancer Patients
A 10% increase in public welfare spending was associated with an 8.6% improvement in 5-year overall survival for Black patients with cancer.
Trials Supporting Cancer Drug Approvals Lack Information on Gender
Of more than 100 studies used to support drug approvals, none reported information on the gender of participants.
Breast Cancer Guidelines May Be Supported by Low-Quality Reviews
Nearly half of the systematic reviews supporting 5 guidelines were of “critically low” quality.
Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
HIPAA Changes Guidance Rules to Help Tackle COVID-19 Pandemic
The goal is to help public health departments collect information vital to their efforts to contain the COVID-19 pandemic.
Fewer Systematic Biopsy Cores May Not Lower PCa Detection Rate
In a study of patients undergoing transperineal prostate biopsy, the detection rate of clinically significant prostate cancer did not differ significantly between targeted biopsy (TB) with fewer systematic biopsy (SB) cores and TB with SB of the whole prostate.
Radiation Therapy After Prostate Surgery Worsens Sexual, Urinary Function
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
Prostate Cancer Immunotherapy Alone Is Not Enough
So far, prostate cancer immunotherapy has shown only modest benefits. To greatly improve outcomes, immunotherapy will need to be combined with other treatments, according to the authors of a recent review.
- Loading...
Loading...
Next post in Prostate Cancer
Loading... 
Loading...